Journal of Contemporary Brachytherapy

eISSN: 2081-2841
ISSN: 1689-832X

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

IMPACT FACTOR

1.4

MNiSW

JCI

0.32

Journal Citation Indicator

CiteScore 2022

2.5

Journal of Contemporary Brachytherapy is indexed in:
Directory of Open Access Journals (DOAJ), EMBASE, Free Medical Journals, Geneva Foundation Free Medical Journals, HINARI Access to Research, International Committee of Medical Journal Editors (ICMJE), Index Copernicus, ISI Master Journal List, ISI Science Citation Index Expanded (SCI-Ex), Polish Minsitry of Science and Higher Education (PMSHE), PubMed, PubMed Central, Polish Medical Library (GBL), SCIRUS, SCOPUS, WorldCat

Join us at Facebook! You will be in continuous touch with the journal!

Journal integrated with

5/2022
vol. 14

Editorial

Letter from the Editor-in-Chief

Adam Chicheł

Journal of Contemporary Brachytherapy

Online publish date: 2022-11-30

Full text

Original paper

Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions

Christopher K. Luminais, Hamidreza Nourzadeh, Eric Aliotta, Kristin Ward, David Cousins, Timothy N. Showalter, Bruce Libby

J Contemp Brachytherapy 2022; 14, 5: 423–428

Online publish date: 2022-10-04

DOI : https://doi.org/10.5114/jcb.2022.120035

Abstract Full text

Original paper

Predictors of poor cosmesis in breast cancer patients treated with adjuvant whole breast radiation therapy plus high-dose-rate interstitial brachytherapy boost after breast conservation surgery

Nasim Feizi, Shole Arvandi, Maryam Feli, Fatemeh Mohammadian, Ziba Zahiri, Azin Shamsi, Ali Bagheri

J Contemp Brachytherapy 2022; 14, 5: 429–437

Online publish date: 2022-11-21

DOI : https://doi.org/10.5114/jcb.2022.121403

Abstract Full text

Original paper

Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study

Artur J. Chyrek, Adam Chicheł, Wojciech M. Burchardt, Grzegorz Bielęda, Małgorzata Jankowska, Jerzy Moczko, Andrzej Roszak

J Contemp Brachytherapy 2022; 14, 5: 438–445

Online publish date: 2022-11-14

DOI : https://doi.org/10.5114/jcb.2022.121134

Abstract Full text

Original paper

The impact of different treatment protocols on achieved radiation doses of high-dose-rate brachytherapy for locally advanced cervical cancer: a comparison between 2 fractions in 1 application and separate applications for each fraction

Ester Jääskeläinen, Maarit Anttila, Jan-Erik Palmgren, Henna Kärkkäinen

J Contemp Brachytherapy 2022; 14, 5: 446–451

Online publish date: 2022-11-02

DOI : https://doi.org/10.5114/jcb.2022.120765

Abstract Full text

Original paper

A comparative study of dosimetric parameters of 3D-printed non-coplanar template-assisted CT-guided iodine-125 seed implantation brachytherapy in patients with inguinal lymph node metastatic carcinomas

Yanhao Liu, Zongyan Shen, Ang Qu, Ping Jiang, Yuliang Jiang, Junjie Wang

J Contemp Brachytherapy 2022; 14, 5: 452–461

Online publish date: 2022-11-30

DOI : https://doi.org/10.5114/jcb.2022.121564

Abstract Full text

Original paper

Percutaneous transhepatic cholangial drainage combined with intra-tumoral iodine-125 seeds implantation and chemotherapy for locally progressive pancreatic head cancer with obstructive jaundice

Liqiu Ji, Wenwen Zhang, Shanhu Hao, Zhiguo Wang, Tingting Ding, Guoxu Zhang

J Contemp Brachytherapy 2022; 14, 5: 462–469

Online publish date: 2022-11-30

DOI : https://doi.org/10.5114/jcb.2022.121563

Abstract Full text

Original paper

Reliability of algebraic sum to evaluate adjuvant pelvic radiotherapy and vaginal cuff brachytherapy cumulative doses in uterine cancers

Michelina Casale, Lorena Draghini, Fabio Trippa, Sara Costantini, Lisa Vicenzi, Letizia Tesei, Alessandro Di Marzo, Fabio Arcidiacono, Marco Italiani, Ernesto Maranzano

J Contemp Brachytherapy 2022; 14, 5: 470–475

Online publish date: 2022-11-15

DOI : https://doi.org/10.5114/jcb.2022.121175

Abstract Full text

Case report

Very high-risk locally advanced prostate ductal adenocarcinoma cured using low-dose-rate brachytherapy, with seminal vesicle implantation in combination with external beam radiotherapy at a biologically effective dose ≥ 220 Gy: two case reports with a long-term follow-up

Keisei Okamoto

J Contemp Brachytherapy 2022; 14, 5: 476–480

Online publish date: 2022-09-21

DOI : https://doi.org/10.5114/jcb.2022.119637

Abstract Full text

Review paper

Single-fraction high-dose-rate brachytherapy: a scoping review on outcomes and toxicities for all disease sites

Mehdi Kazemi, Sarah Nadarajan, Mitchell Kamrava

J Contemp Brachytherapy 2022; 14, 5: 481–494

Online publish date: 2022-11-25

DOI : https://doi.org/10.5114/jcb.2022.121477

Abstract Full text

Educational article

Overcoming pubic arch interference in prostate brachytherapy using steerable needles

Martijn de Vries, Sarah L. Wilby, Antony L. Palmer, Wojciech Polak, Inna O’Hea, Dominic Hodgson, John J. van den Dobbelsteen

J Contemp Brachytherapy 2022; 14, 5: 495–500

Online publish date: 2022-11-30

DOI : https://doi.org/10.5114/jcb.2022.121562

Abstract Full text